前收市價 | 70.45 |
開市 | 70.99 |
買盤 | 69.39 x 200 |
賣出價 | 69.99 x 100 |
今日波幅 | 69.54 - 70.99 |
52 週波幅 | 27.28 - 75.10 |
成交量 | |
平均成交量 | 445,881 |
市值 | 3.681B |
Beta 值 (5 年,每月) | 0.02 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -1.47 |
業績公佈日 | 無 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 79.08 |
In this article, we will take a detailed look at Insiders Are Dumping These 10 Healthcare Stocks. For a quick overview of such stocks, read our article Insiders Are Dumping These 5 Healthcare Stocks. Healthcare-focused investors were nervous when 2024 started, since election years usually do not bode well for the healthcare industry amid policy-related uncertainties. But healthcare stocks […]
Arcellx, Inc. (ACLX) delivered earnings and revenue surprises of 166.67% and 163.52%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Following a hot year of M&A with biotech stocks, we’ll see more of the same in 2024 as drug makers look to build their pipelines ahead of a massive patent cliff. Between now and 2028, pharmaceutical giants stand to lose billions in revenue as blockbuster drug patents expire. According to EY analysts, the top 20 pharmaceutical giants could lose about $180 billion in sales by the end of the decade. It’s part of the reason Johnson & Johnson (NYSE:JNJ) said it would acquire antibody-drug conjugate (